Biocytogen Announces RenLite® Licensing Agreement with Janssen

0
119
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced the signing of a non-exclusive license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Jonson & Johnson.
[Biocytogen Pharmaceuticals (Beijing) Co., Ltd]
Press Release